Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$1.66 - $3.67 $2,003 - $4,429
1,207 Added 241.4%
1,707 $3,000
Q4 2022

Feb 06, 2023

SELL
$2.77 - $5.07 $2,293 - $4,197
-828 Reduced 62.35%
500 $1,000
Q2 2022

Jul 19, 2022

BUY
$3.28 - $6.21 $2,715 - $5,141
828 Added 165.6%
1,328 $5,000
Q1 2022

Apr 29, 2022

BUY
$5.23 - $7.82 $523 - $782
100 Added 25.0%
500 $3,000
Q4 2021

Jan 24, 2022

SELL
$7.29 - $10.97 $1,458 - $2,194
-200 Reduced 33.33%
400 $3,000
Q3 2021

Oct 29, 2021

SELL
$9.01 - $12.01 $3,441 - $4,587
-382 Reduced 38.9%
600 $5,000
Q2 2021

Aug 02, 2021

SELL
$10.17 - $12.64 $4,922 - $6,117
-484 Reduced 33.02%
982 $12,000
Q1 2021

Apr 29, 2021

BUY
$10.88 - $17.05 $1,806 - $2,830
166 Added 12.77%
1,466 $18,000
Q4 2020

Jan 21, 2021

SELL
$9.23 - $18.18 $12,922 - $25,452
-1,400 Reduced 51.85%
1,300 $20,000
Q3 2020

Oct 20, 2020

SELL
$9.38 - $12.48 $938 - $1,248
-100 Reduced 3.57%
2,700 $26,000
Q1 2020

Apr 14, 2020

BUY
$5.05 - $8.85 $1,010 - $1,770
200 Added 7.69%
2,800 $18,000
Q4 2019

Jan 27, 2020

SELL
$8.03 - $11.7 $9,636 - $14,040
-1,200 Reduced 31.58%
2,600 $22,000
Q3 2019

Oct 17, 2019

BUY
$9.05 - $12.22 $1,810 - $2,444
200 Added 5.56%
3,800 $34,000
Q2 2019

Jul 23, 2019

BUY
$8.75 - $13.03 $875 - $1,303
100 Added 2.86%
3,600 $39,000
Q1 2019

Apr 11, 2019

BUY
$7.72 - $12.81 $772 - $1,281
100 Added 2.94%
3,500 $33,000
Q4 2018

Jan 17, 2019

BUY
$9.51 - $16.6 $7,608 - $13,280
800 Added 30.77%
3,400 $39,000
Q3 2018

Nov 02, 2018

BUY
$13.05 - $19.05 $9,135 - $13,335
700 Added 36.84%
2,600 $44,000
Q2 2018

Jul 27, 2018

BUY
$13.9 - $19.8 $9,730 - $13,860
700 Added 58.33%
1,900 $27,000
Q1 2018

Apr 30, 2018

BUY
$16.7 - $26.35 $11,690 - $18,445
700 Added 140.0%
1,200 $23,000
Q4 2017

Feb 01, 2018

BUY
$11.6 - $17.35 $5,800 - $8,675
500
500 $8,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $193M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.